Genome Editing by Matthew Porteus Department of Pediatrics,

Slides:



Advertisements
Similar presentations
Site-specific recombination
Advertisements

An introduction to CRISPR gene engineering
Targeted Gene Modification Genomics (42925) Hariklia Karageorgiou.
TALENs. Transcription activator-like effectors (TALEs) are produced by plant pathogenic bacteria in the genus Xanthomonas Target host cells via type III.
Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:
Molecular Genetics Introduction to The Structures of DNA and RNA
Genetic “Engineering” for Crop Improvement
Forward genetics and reverse genetics
Cermak, Doyle, Christian, Wang, Zhang, Schmidt, Baller, Somia, Bogdanove, Voytas Nucleic Acids Research, March 24, 2011 Shelley Ackerman Journal.
The case:  2005: No production Continued sampling  2006: Detected plants expressing transgene - demonstrated pollen transfer and seed dispersal (Reichman.
1 Jin-Soo Kim Dept. of Chemistry, Seoul National Univ. Center for Genome Engineering, Institute for Basic Science Genome Editing: Challenges and Opportunities.
Gene editing in embryos and germ line
Gene editing: From biblical times to the present
The beginnings of gene editing
Lecture-7 Genome editing CRISPR
I II III Homologous Recombination (HR) Repair of DNA damage Genome instability: recombination between dispersed repetitive sequences Translocation.
Genome Research :142–153 Thomas O. Auer, Karine Duroure, Anne De Cian,
A change in the nucleotide sequence of DNA Ultimate source of genetic diversity Gene vs. Chromosome.
Genome editing to breed better plants
METHODS OF GENOME ENGINEERING: A NEW ERA OF MOLECULAR BIOLOGY
Ali Zarei1,2*, Seyed Mohammad BagherTabei3, Vahid Razban4,5
12.4 Assessment Answers.
Institute of Health and Biomedical Innovation
Presented by : S.Rasoulinejad
Pluripotent stem cell based gene therapy for hematological diseases
A change in the DNA sequence that affects genetic information
Mutations Chapter 12-4.
Box Mutations in BRCA1/2 and Rad51 are associated with breast cancer
Mutations 12-4.
MSc Student Of Hematology
A change in the DNA sequence that affects genetic information
Dieter Steinmetz Universität Tübingen – ZMBP Kurs WS 15/16
Figure 2 Use of CRISPR/Cas9 for genome editing
Figure 3 Endogenous repair of double-strand DNA breaks
Looking forward to genetically edited fruit crops
Given a DNA strand ACTTCA, what is the mRNA strand?
Astrid Breitbart, Charles E. Murry  Cell Stem Cell 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Donald B. Kohn, MD, Caroline Y. Kuo, MD 
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Feasibility of new breeding techniques for organic farming
Volume 7, Issue 1, Pages (April 2014)
Astrid Breitbart, Charles E. Murry  Cell Stem Cell 
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
Itai M. Pessach, MD, PhD, Luigi D. Notarangelo, MD 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
CRISPR genome-editing: A medical revolution
CRISPR: What is it? Biotech Ethics, Fall ‘18.
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gene transfer © 2016 Paul Billiet ODWS.
Genome Editing Technologies: Defining a Path to Clinic
Molecular Therapy - Methods & Clinical Development
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Objective: Explain the main types of mutations
Gene editing - CRISPR/Cas9 System
Gene editing: modifying a gene that was already there
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Molecular Therapy - Nucleic Acids
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
New Tools for Genome Modification in Human Embryonic Stem Cells
CRISPR Craze to Transform Cardiac Biology
Engineering Globin Gene Expression
Presentation transcript:

Genome Editing by Matthew Porteus Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA;

Genome Editing: Definition (2010 Method of the Year, Nature Methods) Genome editing is the precise modification of the nucleotide sequence of the genome. A. Genome editing by mutagenic non-homologous end-joining results in nucleotide modification at a precise spatial location in the genome. B. Genome editing by homologous recombination results in specific and defined changes in the nucleotide content of the genome at a precise spatial location.

Two Basic Approaches to Genome Editing Genome Editing by AAV mediated homologous recombination Genome Editing by using engineered nucleases to create genome specific DNA double-stranded breaks.

Genome Editing Using AAV

Four Different Nuclease Platforms to Create Genome Specific Double-Strand Breaks Homing Endonucleases (HE) Zinc Finger Nucleases (ZFN) Tal Effector Nucleases (TALEN) RNA Guided Endonucleases (RGE, CRISPR/Cas9)

Timeline of Development and Use of Engineered Nucleases in Human Cells 2010-Genome Editing “Method of the Year” 1994 2013 1994-Homing Endonuclease (mammalian cell) 1994-Chimeric Nuclease (in vitro) 1996-Zinc Finger Nuclease (in vitro) 2003-Zinc Finger Nuclease (mammalian cell) 2010-Zinc Finger Nuclease (human clinical trial) TALEN 2010-non-mammalian cell 2011-mammalian cell 2009-TAL effector code 2012 RGE (in vitro) 2013 RGE (mammalian cell)

Genome Editing using Engineered Nucleases by Non-Homologous End Joining-I TALENs HEs RGE (CRISPR/Cas9) ZFNs * Insertions/Deletions at Site of Engineered Nuclease Break (Enhanced by Expression of TREX-2 in certain circumstances) (To mutate a gene or restore a reading frame)

Intra-chromosomal Deletion by Creating Two DSBs on Same Chromosome Genome Editing using Engineered Nucleases by Non-Homologous End Joining-II TALENs HEs TALENs HEs RGE (CRISPR/Cas9) RGE (CRISPR/Cas9) ZFNs ZFNs Intra-chromosomal Deletion by Creating Two DSBs on Same Chromosome

Genome Editing using Engineered Nucleases by Non-Homologous End Joining-III TALENs HEs TALENs HEs RGE (CRISPR/Cas9) RGE (CRISPR/Cas9) ZFNs ZFNs Chromosome A Chromosome B Chromosomal Translocation Created by Joining of Two Simultaneous DSBs on Different Chromosomes

Genome Editing using Engineered Nucleases by Single Strand Annealing (combination of NHEJ and HR) TALENs HEs RGE (CRISPR/Cas9) ZFNs Reduction of Repeat Element by Creating a Break in the Sequence Between the Two Repeats

Genome Editing using Engineered Nucleases by Homologous Recombination TALENs HEs RGE (CRISPR/Cas9) ZFNs Donor DNA Donor DNA Single/Small Defined Nucleotide Change Targeted Transgene(s) Insertion